Jean Campbell is nationally recognized as one of the leading rare disease patient advocate with an impressive record of success in fundraising and corporate relations. After serving nearly two decades with the National Organization for Rare Disorders (NORD) she retired as Vice-President of Membership Development after spending over ten years mentoring and consulting with many nonprofit organizations and their board of directors. Under Jean's leadership, there was significant expansion of several of NORD's membership programs along with the creation of NORD's restricted research, medical meeting, organization mentor and clinical broadcast programs. Jean also played a key role in the establishment of the NORD Corporate Council, which has grown to 50 pharmaceutical and biotechnology companies.
A well-respected and extremely connected resource in the rare disease health community, Jean has now created her own consulting company, JF CAMPBELL CONSULTANTS LLC. Her expertise in non-profit strategic planning, organizational governance, corporate relations and program management is extremely valuable to all size organizations. Her clients are the non-profit health community, pharmaceutical corporations, and biotech industries. The primary goal of her services is to increase a client's national and international visibility in the health industry as well as create productive partnerships, effective strategic planning, and optimal program development. In addition, Jean provides valuable mentorship to start-up and growing patient organizations helping to strengthen their infrastructure in order to better serve their mission, members and communities.
Jean F. Campbell is a member of the Advisory Board of Medunik USA.